TG Therapeutics (TGTX) had the highest return between April 2, 2023 and May 1, 2023 by a mid-cap US stock, returning 104.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
TG Therapeutics (TGTX) | 4/2/2023 - 5/1/2023 | 104.13% |
Trevi Therapeutics (TRVI) | 4/2/2023 - 5/1/2023 | 78.34% |
Soleno Therapeutics (SLNO) | 4/2/2023 - 5/1/2023 | 73.81% |
Immunitybio (IBRX) | 4/2/2023 - 5/1/2023 | 67.39% |
Disc Medicine (IRON) | 4/2/2023 - 5/1/2023 | 63.18% |
Nuvalent (NUVL) | 4/2/2023 - 5/1/2023 | 50.02% |
Arcellx (ACLX) | 4/2/2023 - 5/1/2023 | 43.02% |
Legend Biotech (LEGN) | 4/2/2023 - 5/1/2023 | 42.64% |
Edgewise Therapeutics (EWTX) | 4/2/2023 - 5/1/2023 | 42.47% |
Brookdale Senior Living (BKD) | 4/2/2023 - 5/1/2023 | 41.61% |
Ideaya Biosciences (IDYA) | 4/2/2023 - 5/1/2023 | 40.93% |
Praxis Precision Medicines (PRAX) | 4/2/2023 - 5/1/2023 | 34.94% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 4/2/2023 - 5/1/2023 | 31.91% |
Viking Therapeutics (VKTX) | 4/2/2023 - 5/1/2023 | 31.47% |
Life Time (LTH) | 4/2/2023 - 5/1/2023 | 31.31% |
StoneCo (STNE) | 4/2/2023 - 5/1/2023 | 30.95% |
Arcutis Biotherapeutics (ARQT) | 4/2/2023 - 5/1/2023 | 30.34% |
Vaxcyte (PCVX) | 4/2/2023 - 5/1/2023 | 29.28% |
Crinetics Pharmaceuticals (CRNX) | 4/2/2023 - 5/1/2023 | 28.29% |
CleanSpark (CLSK) | 4/2/2023 - 5/1/2023 | 26.67% |
SkyWest (SKYW) | 4/2/2023 - 5/1/2023 | 25.55% |
Centessa Pharmaceuticals PLC ADR (CNTA) | 4/2/2023 - 5/1/2023 | 23.48% |
UWM (UWMC) | 4/2/2023 - 5/1/2023 | 22.43% |
Bel Fuse A (BELFA) | 4/2/2023 - 5/1/2023 | 22.18% |
Crane NXT (CXT) | 4/2/2023 - 5/1/2023 | 21.34% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.